Typ av förfarandeFörhandlat förfarande utan föregående offentliggörandeFörklaring:
The chromium instrument from 10x genomics is routinely used in the operations at NGI Stockholm to utilize the unique linked-reads technology developed by the company. The reagent kits required to run the instrument are solely provided by 10x genomics as they are protected by patents (US Pat. No 9,644,204, US Pat. No 9,975,122, US Pat. No 10,053,723) and no alternatives are thus available on the market.
There are other companies offering products for spatial transcriptomics inference but their products offer targeted assays targeting a subset of distinct RNA. This stands in contrast to the visium spatial solution by 10x genomics as visium enables global expression inference for any poly-adenlylated mRNA, i.e. transciptome-wide, non-targeted spatial transciptomics. visium spatial reagent kits from 10x genomics are protected by patents (US Pat. No 10,030,261, US Pat No 9,593,365, US Pat No 9,371,598, US Pat No 10,308,982, US Pat No 9,868,979 and US Pat No 9,879,313).